[Mechanisms of the inotropic action of nonachlazine].
作者信息
Kaverina N V, Katsenovich R A, Tkachenko B I, Iunusov Z Z, Ovsiannikov V I
出版信息
Farmakol Toksikol. 1985 Jan-Feb;48(1):23-7.
PMID:3979531
Abstract
It has been demonstrated clinically and experimentally that administration of nonachlazine enhances myocardial contractility because of the stimulation of beta-adrenostructures and that the initial status of the latter ones determines in many respects the drug action intensity.
摘要
Zotero 插件